BCRX icon

BioCryst Pharmaceuticals
BCRX

Overview Fund Activity

115 hedge funds and large institutions have $283M invested in BioCryst Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 35 reducing their positions, and 17 closing their positions.

Holders
115
Holders Change
-1
Holders Change %
-0.86%
% of All Funds
2.53%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
16
Increased
37
Reduced
35
Closed
17
Calls
$1.02M
Puts
$185K
Net Calls
+$838K
Net Calls Change
+$858K

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$9.34M
2
Capital World Investors
2
Capital World Investors
California
$8.14M
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$4.66M
4
CS
4
Credit Suisse
Switzerland
$3.36M
5
UBS Group
5
UBS Group
Switzerland
$8.7M

Top Sellers

1
DM
1
Deerfield Management
New York
$7.95M
2
Invesco
2
Invesco
Georgia
$0
3
State Street
3
State Street
Massachusetts
$13.9M
4
BBA
4
Baker Bros. Advisors
New York
$36.5M
5
SSA
5
Schonfeld Strategic Advisors
New York
$2.61M
Name Market Value Shares Shares
Change 		Shares
Change %
BBA
1
Baker Bros. Advisors
New York
$36.5M 12,725,472 -1,657,201 -12%
BlackRock
2
BlackRock
New York
$27.5M 9,594,780 +668,889 +7%
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$27.3M 9,520,564 -75,780 -0.8%
Millennium Management
4
Millennium Management
New York
$22.2M 7,763,335 +667,038 +9%
Vanguard Group
5
Vanguard Group
Pennsylvania
$17.1M 5,978,921 -713,523 -11%
State Street
6
State Street
Massachusetts
$13.9M 4,861,776 -1,783,941 -27%
Citadel Advisors
7
Citadel Advisors
Florida
$11M 3,833,471 +340,873 +10%
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$9.34M 3,260,000 +3,260,000 New
UBS Group
9
UBS Group
Switzerland
$8.7M 3,037,809 +835,015 +38%
VMI
10
VHCP Management II
New York
$8.24M 2,874,602 – –
Capital World Investors
11
Capital World Investors
California
$8.14M 2,840,000 +2,498,679 +732%
DM
12
Deerfield Management
New York
$7.95M 2,774,643 -3,518,337 -56%
VMI
13
VHCP Management III
New York
$7.76M 2,708,207 – –
Fidelity Investments
14
Fidelity Investments
Massachusetts
$5.12M 1,788,541 -1,106,200 -38%
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$4.75M 1,657,379 +166,025 +11%
Jacobs Levy Equity Management
16
Jacobs Levy Equity Management
New Jersey
$4.66M 1,627,785 +1,627,785 New
GTC
17
Ghost Tree Capital
New York
$4.3M 1,500,000 -1,000,000 -40%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$4.25M 1,483,362 -3,237 -0.2%
Northern Trust
19
Northern Trust
Illinois
$3.92M 1,367,802 +4,753 +0.3%
Morgan Stanley
20
Morgan Stanley
New York
$3.58M 1,248,316 -164,337 -12%
CS
21
Credit Suisse
Switzerland
$3.36M 1,171,439 +1,023,363 +691%
Goldman Sachs
22
Goldman Sachs
New York
$2.99M 1,042,631 +36,924 +4%
SSA
23
Schonfeld Strategic Advisors
New York
$2.61M 911,300 -1,322,400 -59%
Two Sigma Advisers
24
Two Sigma Advisers
New York
$2.51M 874,912 +435,300 +99%
Nuveen Asset Management
25
Nuveen Asset Management
Illinois
$2.36M 822,882 +4,649 +0.6%
1
2 3 4 5